The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $13.40

Today's change-0.15 -1.11%
Updated March 29 11:22 AM EDT. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $13.40

Today's change-0.15 -1.11%
Updated March 29 11:22 AM EDT. Delayed by at least 15 minutes.

Reversal following new 20-day high

Meridian Bioscience Inc is lower today, dropping (U.S.)$0.15 or 1.11% to (U.S.)$13.40 after setting a new 20-day high. Over the last five days, shares have gained 4.69%, but are down 24.29% for the last year to date. Shares have underperformed the S&P 500 by 51.65% during the last year.

Key company metrics

  • Open(U.S.) $13.50
  • Previous close(U.S.) $13.55
  • High(U.S.) $13.70
  • Low(U.S.) $13.35
  • Bid / Ask(U.S.) $13.40 / (U.S.) $13.45
  • YTD % change-24.29%
  • Volume72,842
  • Average volume (10-day)305,935
  • Average volume (1-month)370,032
  • Average volume (3-month)407,691
  • 52-week range(U.S.) $10.75 to (U.S.) $21.49
  • Beta0.95
  • Trailing P/E19.21×
  • P/E 1 year forward20.53×
  • Forward PEG1.21×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield3.73%
  • Trailing EPS(U.S.) $0.70
Updated March 29 11:22 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue47475151
Total other revenue--------
Total revenue47475151
Gross profit29303334
Total cost of revenue17171818
Total operating expense37383736
Selling / general / administrative16161615
Research & development3443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--10--
Other operating expenses, total--------
Operating income1091415
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1091315
Income after tax6599
Income tax, total3356
Net income6599
Total adjustments to net income--------
Net income before extra. items6599
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6599
Inc. avail. to common incl. extra. items6599
Diluted net income6599
Dilution adjustment------0
Diluted weighted average shares43424242
Diluted EPS excluding extraordinary itemsvalue per share0.150.130.210.21
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.150.140.210.21